Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future. PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

Detailed Description
-----------------
OBJECTIVES: Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies. OUTLINE: This is a pilot, prospective, longitudinal study. Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review. PROJECTED ACCRUAL: Not specified

Official Title
-----------------
Outcomes Following Image-Guided Therapy for Hepatic Malignancies

Conditions
-----------------
Liver Cancer, Metastatic Cancer

Intervention / Treatment
-----------------
* Other: medical chart review
* Other: questionnaire administration
* Procedure: quality-of-life assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques: X-ray Ultrasound MRI CT scan Nuclear medicine imaging PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: See Disease Characteristics

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Image-guided Therapy<br>Patients undergoing Image-guided Therapy of Hepatic Neoplasms. | Other: medical chart review<br>* Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.<br>* Other names: Embolization;Other: questionnaire administration<br>* Patients with hepatic neoplasms who undergo Image-guided Therapy<br>* Other names: Chemo-embolization;Procedure: quality-of-life assessment<br>* Patients with hepatic neoplasms who undergo Image-guided Therapy<br>* Other names: Chemoembolization;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Development of a data repository for clinical outcome measures by conducting a medical record review at baseline, during routine follow-up after image-guided therapy, and then annually thereafter |  | one year | 
| Development of a data repository for health-related quality of life outcome measures by administering the Medical Outcomes Study Short Form questionnaire at baseline, during routine follow-up after image-guided therapy, and then annually thereafter |  | one year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
adult primary liver cancer, liver metastases